Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The colonic luminal osmotic gradient is a physiological mechanism rather than a specific molecular target like a receptor or enzyme. It represents the difference in osmotic pressure between the contents of the colonic lumen and the surrounding mucosal tissue, which governs the passive movement of water across the intestinal epithelium (StatPearls: Laxatives, https://www.ncbi.nlm.nih.gov/books/NBK537246/). This gradient is the primary therapeutic target for osmotic laxatives, which are used to treat constipation and for bowel cleansing before medical procedures (PubMed: PMC3571893, https://pubmed.ncbi.nlm.nih.gov/21382153/). By introducing poorly absorbed solutes—such as salts, sugars, or polymers—into the colon, these agents increase the luminal osmolarity, thereby drawing water into the bowel to soften stool and stimulate peristalsis (StatPearls: Laxatives; NIH: StatPearls - Lactulose, https://www.ncbi.nlm.nih.gov/books/NBK536930/). While highly effective, manipulating this gradient can lead to clinical challenges such as electrolyte disturbances and dehydration, particularly in vulnerable populations (StatPearls: Laxatives). This mechanism is also utilized in the treatment of hepatic encephalopathy, where agents like lactulose create an osmotic effect while also acidifying the lumen to trap ammonia (NIH: StatPearls - Lactulose).
Osmotic retention of water in the intestinal lumen
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic luminal osmotic gradient.